Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 4/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | DRD4 | P21917 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24028645 | 0.89 | PRKDC (0.34) | PRKDCPIK3CDPIK3CBALOX5MEN1 | |
| SCHEMBL24028696 | 0.88 | ALOX5 (0.39) | PRKDCPIK3CDPIK3CBALOX5MEN1 | |
| SCHEMBL24028644 | 0.88 | CDC14B (0.33) | CYP2C19 | |
| SCHEMBL24028560 | 0.86 | ALOX5 (0.37) | PRKDCPIK3CDPIK3CBALOX5MEN1 | |
| SCHEMBL24028735 | 0.86 | PIK3CA (0.35) | PIK3CDPIK3CB | |
| SCHEMBL24028647 | 0.85 | CHEK2 (0.35) | MEN1KMT2A | |
| SCHEMBL24028646 | 0.85 | PTGER4 (0.33) | PRKDCMEN1KMT2A | |
| SCHEMBL24943502 | 0.85 | ALOX5 (0.43) | PRKDCPIK3CDPIK3CBALOX5MEN1 | |
| SCHEMBL16810896 | 0.84 | ALOX5 (0.41) | PRKDCPIK3CDPIK3CBALOX5MEN1 | |
| SCHEMBL24029055 | 0.83 | KDM4E (0.37) | MEN1CYP2C19KMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210359215-A1 | COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210359215-A1 | COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, SIRT1 | PRKDC 3964/4885PIK3CD 4069/4885PIK3CB 4226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.